Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients
NCT ID: NCT01263652
Last Updated: 2020-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2010-12-31
2019-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The patients will receive both intra-muscular and oral non-narcotic analgesics and placebo. During the study period, pain reduction parameters will be collected. At the end of the study period, the investigators will attempt to find a correlation between pre-study patient preferences and the quality of the pain reduction achieved.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of the Endogenous Opioid System Underlying Modulation of Experimental Pain
NCT01327326
A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day
NCT00952068
Orphenadrine and Methocarbamol for LBP
NCT02665286
Apomorphine Effects on Experimental Pain
NCT01744964
Endogenous Opioid Response to Injections
NCT06666621
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IMmed
Patients receiving intra-muscular medication and oral placebo
Diclofenac hydroxyethylpyrrolidine
IM/PO
orphenadrine
IM/PO orphenadrine
Tramadol
IM/PO tramadol
Dipyrone
PO/IM Dipyrone
POmed
Patients receiving intra-muscular placebo and oral medication
Diclofenac hydroxyethylpyrrolidine
IM/PO
orphenadrine
IM/PO orphenadrine
Tramadol
IM/PO tramadol
Dipyrone
PO/IM Dipyrone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diclofenac hydroxyethylpyrrolidine
IM/PO
orphenadrine
IM/PO orphenadrine
Tramadol
IM/PO tramadol
Dipyrone
PO/IM Dipyrone
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
15 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Western Galilee Hospital-Nahariya
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nimrod Rahamimov
Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nimrod Rahamimov, M.D.
Role: PRINCIPAL_INVESTIGATOR
Western Galilee Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SpinePainIMPO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.